[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]

The current S3 Lung Cancer Guidelines are edited with fundamental changes to the previous edition based on the dynamic influx of information to this field:The recommendations include de novo a mandatory case presentation for all patients with lung cancer in a multidisciplinary tumor board before initiation of treatment, furthermore CT-Screening for asymptomatic patients at risk (after federal approval), recommendations for incidental lung nodule management , molecular testing of all NSCLC independent of subtypes, EGFR-mutations in resectable early stage lung cancer in relapsed or recurrent disease, adjuvant TKI-therapy in the presence of common EGFR-mutations, adjuvant consolidation treatment with checkpoint inhibitors in resected lung cancer with PD-L1

• Schütte, W.
• Gütz, S.
• Nehls, W.
• Blum, T. G.
• Brückl, W.
• Buttmann-Schweiger, N.
• Büttner, R.
• Christopoulos, P.
• Delis, S.
• Deppermann, K. M.
• Dickgreber, N.
• Eberhardt, W.
• Eggeling, S.
• Fleckenstein, J.
• Flentje, M.
• Frost, N.
• Griesinger, F.
• Grohé, C.
• Gröschel, A.
• Guckenberger, M.
• Hecker, E.
• Hoffmann, H.
• Huber, R. M.
• Junker, K.
• Kauczor, H. U.
• Kollmeier, J.
• Kraywinkel, K.
• Krüger, M.
• Kugler, C.
• Möller, M.
• Nestle, U.
• Passlick, B.
• Pfannschmidt, J.
• Reck, M.
• Reinmuth, N.
• Rübe, C.
• Scheubel, R.
• Schumann, C.
• Sebastian, M.
• Serke, M.
• Stoelben, E.
• Stuschke, M.
• Thomas, M.
• Tufman, A.
• Vordermark, D.
• Waller, C.
• Wolf, J.
• Wolf, M.
• Wormanns, D.